Biological
Mesenchymal Stem Cell Infusion
Mesenchymal Stem Cell Infusion is a biological therapy with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
20%
Ph early_phase_1
2
40%
Ph phase_1
2
40%
Phase Distribution
4
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Early Phase 1First-in-human
2(40.0%)
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
1(20.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(2)
Other(2)
Detailed Status
Completed2
unknown2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Early Phase 12 (40.0%)
Phase 12 (40.0%)
Phase 21 (20.0%)
Trials by Status
recruiting120%
completed240%
unknown240%
Recent Activity
1 active trials
Showing 5 of 5
recruitingearly_phase_1
Safety and Efficacy of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in the Treatment of Long-Term Cytopenia After CAR-T Therapy
NCT07212335
completedphase_1
Mesenchymal Stem Cells and Subclinical Rejection
NCT00734396
unknownearly_phase_1
Mesenchymal Stem Cell for Osteonecrosis of the Femoral Head
NCT00813267
completedphase_2
Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease
NCT00504803
unknownphase_1
Evaluation of the Role of Mesenchymal Stem Cells in the Treatment of Graft Versus Host Disease
NCT00314483
Clinical Trials (5)
Showing 5 of 5 trials
NCT07212335Early Phase 1
Safety and Efficacy of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in the Treatment of Long-Term Cytopenia After CAR-T Therapy
NCT00734396Phase 1
Mesenchymal Stem Cells and Subclinical Rejection
NCT00813267Early Phase 1
Mesenchymal Stem Cell for Osteonecrosis of the Femoral Head
NCT00504803Phase 2
Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease
NCT00314483Phase 1
Evaluation of the Role of Mesenchymal Stem Cells in the Treatment of Graft Versus Host Disease
All 5 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 5